Which guidelines have been issued on the treatment of Behçet disease?

Updated: Dec 21, 2020
  • Author: Nicole Davey-Ranasinghe, MD; Chief Editor: Herbert S Diamond, MD  more...
  • Print

The treatment approach depends on the individual patient, severity of disease, and major organ involvement. The European League Against Rheumatism (EULAR) recommendations for the management of Behçet disease, which were developed in 2008 and updated in 2018, aid in the management of different aspects of Behçet disease. [45, 46] Recommendations related to the eye, skin/mucosa, and arthritic disease are mainly evidence based, but recommendations on vascular, neurological, and gastrointestinal involvement are based largely on expert opinion and uncontrolled evidence from open trials and observational studies. [45, 46]

As disease activity subsides, taper medications to the lowest dose that effectively controls disease activity. Inpatient care is based on individual organ-system involvement. Individualize the transfer situation for each patient based on the specifics of organ-system involvement.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!